ライフサイエンスコーパス: bipolar disorder

1 ular imaging studies of dopamine function in bipolar disorder.

2 in the membrane phospholipids metabolism in bipolar disorder.

3 of a high polygenic risk of schizophrenia or bipolar disorder.

4 ehavior, suggestive of some aspects of human bipolar disorder.

5 yet shown antidepressant efficacy in MDD and bipolar disorder.

6 eater genetic overlap with schizophrenia and bipolar disorder.

7 activation represent distinct dimensions of bipolar disorder.

8 these systems have been implicated, such as bipolar disorder.

9 agonists in the treatment and prophylaxis of bipolar disorder.

10 d in both chronic schizophrenia and euthymic bipolar disorder.

11 endations for the psychological treatment of bipolar disorder.

12 t and key negative outcomes in patients with bipolar disorder.

13 ll comorbidities except for schizophrenia or bipolar disorder.

14 t step forward in the clinical management of bipolar disorder.

15 h clinical features and course of illness in bipolar disorder.

16 stently been implicated in schizophrenia and bipolar disorder.

17 symptoms and executive function deficits in bipolar disorder.

18 NP) rs11764590 in MAD1L1 was associated with bipolar disorder.

19 ts occurring during maintenance treatment of bipolar disorder.

20 nd Care Excellence-recommended treatment for bipolar disorder.

21 of irritability, a symptom of both DMDD and bipolar disorder.

22 risk of converting to both schizophrenia and bipolar disorder.

23 diastolic blood pressure, serum albumin, and bipolar disorder.

24 ted in the pathogenesis of schizophrenia and bipolar disorder.

25 d may help to identify novel drug targets in bipolar disorder.

26 reas NRXN1-alpha expression was increased in bipolar disorder.

27 erlying pathophysiology of schizophrenia and bipolar disorder.

28 ured peer support for patients with remitted bipolar disorder.

29 ease in FA in the left posterior cingulum in bipolar disorder.

30 NF804A) is associated with schizophrenia and bipolar disorder.

31 ne, which codes for the Cav1.3 protein, with bipolar disorder.

32 1 patients with major depressive disorder or bipolar disorder.

33 of the sensorimotor network in patients with bipolar disorder.

34 ) and between openness and schizophrenia and bipolar disorder.

35 -52.3) converting to either schizophrenia or bipolar disorder.

36 stance-induced psychosis to schizophrenia or bipolar disorder.

37 nset in unaffected siblings of patients with bipolar disorder.

38 s the public health impact for patients with bipolar disorder.

39 ted in schizophrenia, Tourette syndrome, and bipolar disorder.

40 ood-stabilizing medication, in patients with bipolar disorder.

41 nd depression episodes that is a hallmark of bipolar disorder.

42 cluding schizophrenia, major depression, and bipolar disorders.

43 [0.55-0.74]), diagnosis of schizophrenia or bipolar disorder (0.55 [0.44-0.67]), cardiometabolic com

44 ve disorder (235.1 per 100000 person-years), bipolar disorder (216.0 per 100000 person-years), schizo

45 yped a Norwegian sample of 402 patients with bipolar disorder, 293 patients with schizophrenia, and 3

46 uding 29 analyses of the factor structure of bipolar disorder, 3 of activity data from experimental s

47 (736 patients vs. 668 control subjects) and bipolar disorder (536 patients vs. 489 control subjects)

48 onal MRI data acquired from 78 patients with bipolar disorder, 64 unaffected siblings, and 41 healthy

49 1 men included in the cohort, 4310 developed bipolar disorder; 784, schizoaffective disorder; 4823, s

50 as observed among adolescents with past-year bipolar disorder (94.2 [1.69]; P = .004), attention-defi

51 on studies have implicated the ANK3 locus in bipolar disorder, a major human psychotic illness.

52 n patients with major depressive disorder or bipolar disorder, abnormalities in excitatory and/or inh

53 Bipolar disorder affects up to one in 25 individuals and

54 the rates of conversion to schizophrenia and bipolar disorder after a substance-induced psychosis, as

55 Lithium is widely used as a treatment for Bipolar Disorder although the molecular mechanisms that

56 nd psychiatric disorders like schizophrenia, bipolar disorder, Alzheimer's disease and autism, while

57 ommonly comorbid disorders of schizophrenia, bipolar disorder, Alzheimer's disease, and coronary arte

58 the inclusion criteria (18 schizophrenia, 16 bipolar disorder and 12 MDD) for chronically ill patient

59 Twenty euthymic bipolar disorder and 19 matched control participants pla

60 6039769, that is associated with early-onset bipolar disorder and a higher gene expression level in h

61 to determine relapse rates for patients with bipolar disorder and a history of postpartum episodes.

62 e altered in a range of disorders, including bipolar disorder and Alzheimer's disease.

63 s, attention-deficit hyperactivity disorder, bipolar disorder and antisocial personality disorder, ea

64 hanism both in schizophrenia and early-onset bipolar disorder and confirm the shared genetic vulnerab

65 ther activation is statistically abnormal in bipolar disorder and demonstrably distinct from mood, an

66 ers, such as post-traumatic stress disorder, bipolar disorder and depression, are also associated wit

67 anisms mediating irritability differ between bipolar disorder and DMDD, using a face emotion labeling

68 -wide association study based on CSF KYNA in bipolar disorder and found support for an association wi

69 Patients with bipolar disorder and history of childhood maltreatment h

70 pitulates some of the core features of human bipolar disorder and indicates that cortical microcircui

71 rominent cause of morbidity in patients with bipolar disorder and is strongly associated with suicide

72 s a potential developmental role for NRG3 in bipolar disorder and major depression.

73 and have been associated with schizophrenia, bipolar disorder and major depression.

74 Schizophrenia, bipolar disorder and major depressive disorder (MDD) hav

75 ajor mood disorders, which primarily include bipolar disorder and major depressive disorder, are the

76 chiatric disorders, including schizophrenia, bipolar disorder and major depressive disorder.

77 subjects with SZ, but rare in subjects with bipolar disorder and major depressive disorder.

78 schizophrenia, euthymic (but not depressed) bipolar disorder and MDD compared with controls (P<0.01)

79 Participants aged 18 years or older with bipolar disorder and no episode in the preceding 4 weeks

80 l approach to innovative pharmacotherapy for bipolar disorder and related phenotypes.

81 We applied EPS to the bipolar disorder and schizophrenia GWAS from the Psychia

82 ational Classification of Diseases codes for bipolar disorder and schizophrenia spectrum disorders.

83 reduced in number in post mortem studies of bipolar disorder and schizophrenia, and in chronically-s

84 stress increases adult risk for depression, bipolar disorder and schizophrenia, illnesses characteri

85 ry, including depression, anxiety disorders, bipolar disorder and schizophrenia.

86 ficient-like 1) as a susceptibility gene for bipolar disorder and schizophrenia.

87 apacity as a potential novel drug target for bipolar disorder and schizophrenia.

88 crease the vulnerability to both early-onset bipolar disorder and schizophrenia.SIGNIFICANCE STATEMEN

89 sociated dysconnectivity in individuals with bipolar disorder and their first-degree relatives.

90 symptoms are a major cause of disability in bipolar disorder and there are few safe and effective tr

91 We included patients who had a diagnosis of bipolar disorder and were prescribed lithium (n = 2148),

92 ostpartum relapse in patients diagnosed with bipolar disorder and/or a history of postpartum psychosi

93 h a schizophrenia spectrum disorder, 26 with bipolar disorder) and 50 age-matched healthy control sub

94 cquisition, 71 youths (25 with DMDD, 24 with bipolar disorder, and 22 healthy youths) performed a lab

95 l 4,360 participants met DSM-IV criteria for bipolar disorder, and 310 met DSM-IV criteria for a mani

96 hiatric conditions, including schizophrenia, bipolar disorder, and attention-deficit/hyperactivity di

97 chiatric disorders, including schizophrenia, bipolar disorder, and autism spectrum disorder.

98 ng the familial clustering of schizophrenia, bipolar disorder, and autism spectrum disorders (ASD).

99 lnesses including schizophrenia, depression, bipolar disorder, and autism.

100 NRG3 class II was increased in bipolar disorder, and class III was increased in major d

101 unced in schizophrenia (SZ), intermediate in bipolar disorder, and least in major depressive disorder

102 tial shared genetic risk with schizophrenia, bipolar disorder, and major depressive disorder and to i

103 ed comparison subjects and subjects with SZ, bipolar disorder, and major depressive disorder, and the

104 ritability with extraversion, schizophrenia, bipolar disorder, and major depressive disorder.

105 We tested whether the genetic load for MDD, bipolar disorder, and schizophrenia (SCZ) is increased i

106 Genomic profile risk scores (GPRSs) for MDD, bipolar disorder, and SCZ were based on meta-analysis re

107 f unintentional injury are poorly defined in bipolar disorder, and understanding drug associations wi

108 , including major depressive disorder (MDD), bipolar disorder, anxiety disorders, and schizophrenia.

109 orders.SIGNIFICANCE STATEMENT Depression and bipolar disorder are the most common mood disorders.

110 betes insipidus (lithium-NDI), patients with bipolar disorder are treated with thiazide and amiloride

111 has multiple alternative first exons, and a bipolar disorder-associated ANK3 variant has been shown

112 One bipolar disorder-associated rare variant (M2145T) in TGE

113 trum disorders in youths at familial risk of bipolar disorder ("at-risk" youths).

114 , with a focus on depression, schizophrenia, bipolar disorder, autism, anxiety and attention deficit/

115 volumes and specific mood disorders, such as bipolar disorder (BD) and major depressive disorder (MDD

116 Both bipolar disorder (BD) and major depressive disorder (MDD

117 Schizophrenia (SCZ), bipolar disorder (BD) and recurrent major depressive dis

118 ics in psychiatric disorders, including both bipolar disorder (BD) and schizophrenia.

119 e degree to which major depression (MDD) and bipolar disorder (BD) are associated with common and/or

120 for schizophrenia (SZ), but the findings for bipolar disorder (BD) are less clear.

121 Bipolar disorder (BD) is a common, complex and heritable

122 Bipolar disorder (BD) is a highly heritable and heteroge

123 Bipolar disorder (BD) is a leading cause of global disab

124 Bipolar disorder (BD) is a progressive psychiatric disor

125 Bipolar disorder (BD) is a severe psychiatric illness af

126 Bipolar disorder (BD) is characterized by a dysregulatio

127 decades of research, the pathophysiology of bipolar disorder (BD) is still not well understood.

128 rs, such as major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SCZ).

129 fied several common variants associated with bipolar disorder (BD), but the biological meaning of the

130 m is the mainstay prophylactic treatment for bipolar disorder (BD), but treatment response varies con

131 T1D), type 2 diabetes (T2D), psoriasis (PS), bipolar disorder (BD), coronary artery disease (CAD), hy

132 Complex disorders, such as bipolar disorder (BD), likely result from the influence

133 ntified CACNA1C as a candidate risk gene for bipolar disorder (BD), schizophrenia (SCZ), major depres

134 For bipolar disorder (BD), the clinical states are remission

135 ence supports a neurodevelopmental model for bipolar disorder (BD), with adolescence as a critical pe

136 n to familial risk and disease expression in bipolar disorder (BD).

137 he brain's network in schizophrenia (SZ) and bipolar disorder (BD).

138 de association studies to be associated with bipolar disorder (BD).

139 t the defining brain changes associated with bipolar disorder (BD).

140 lockDelta19) are used as an animal model for bipolar disorder (BD).

141 -cortical circuits in schizophrenia (SZ) and bipolar disorder (BD).

142 zophrenia, obsessive-compulsive disorder and bipolar disorder (BD).

143 somatostatin (SST) in schizophrenia (SZ) and bipolar disorder (BD).

144 s anticipation in depressed individuals with bipolar disorder (BDD) versus depressed individuals with

145 lygenic risk scores (PRS) for schizophrenia, bipolar disorder, BMI, waist-hip-ratio, insulin resistan

146 sive disorder (MDD), schizophrenia (SCZ) and bipolar disorder (BP) are common, disabling and heritabl

147 arch on resting functional brain networks in bipolar disorder (BP) has been unable to differentiate b

148 ng studies compare individuals affected with bipolar disorder (BP), at high familial risk of BP, and

149 nd circadian rhythms are central features of bipolar disorder (BP), often persisting between episodes

150 rder) were indistinguishable from those with bipolar disorder (BP)-II on clinical bipolar validators,

151 have reported hundreds of genes connected to bipolar disorder (BP).

152 on-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BPD) are frequently co-occurring and h

153 trum disorder (ASD), schizophrenia (SCZ) and bipolar disorder (BPD) are of great societal and medical

154 on, a core feature of schizophrenia (SZ) and bipolar disorder (BPD), and use functional magnetic reso

155 cases in each of four groups: schizophrenia, bipolar disorder (BPD), major depression (MD) and unaffe

156 ithium remains the gold standard in treating bipolar disorder but has unwanted toxicity and side effe

157 the correlation with violent criminality in bipolar disorder but none of the same correlation in sch

158 disorder is considered as a severe course of bipolar disorder, but it is unclear whether rapid cyclin

159 em brains of patients with schizophrenia and bipolar disorder by conducting a meta-analysis of existi

160 ein Ankyrin-G (AnkG), has been implicated in bipolar disorder by genome-wide association studies.

161 mproves depressive symptoms in patients with bipolar disorder by modulating function in components of

162 nia (Cohen d = 0.36, P < .001) and psychotic bipolar disorder (Cohen d = 0.33, P = .002) had signific

163 ing euthymia and depression in patients with bipolar disorder compared with healthy controls and othe

164 h increased gene expression in patients with bipolar disorder compared with healthy subjects.

165 ment of daytime activity in individuals with bipolar disorder compared with other clinical or healthy

166 tive lack of habituation among patients with bipolar disorders compared with others.

167 In women with bipolar disorder, continuation of prophylactic medicatio

168 cent and young adult suicide attempters with bipolar disorder demonstrate less gray matter volume and

169 alization with a diagnosis of schizophrenia, bipolar disorder, depression, or anxiety was significant

170 s followed longitudinally, with diagnoses of bipolar disorder, depression, schizoaffective disorder a

171 henotype including behavior changes modeling bipolar disorder, epilepsy and sudden death.

172 havioral disorders, including schizophrenia, bipolar disorder, epilepsy, autism, Alzheimer's disease,

173 he brains of patients with schizophrenia and bipolar disorder exhibit decreased brain pH relative to

174 ychotic symptom severity in individuals with bipolar disorder experiencing a current psychotic episod

175 GPRS-bipolar disorder explained 0.6% (p = 2.97e(-05)) of MDD

176 quality of life of millions of patients with bipolar disorder for >60 years.

177 channel (LTCC) antagonists have been used in bipolar disorder for over 30 years, without becoming an

178 inal assessment are crucial to differentiate bipolar disorder from other conditions.

179 f the first genes to reach significance in a bipolar disorder genome-wide association study.

180 As predicted, the bipolar disorder group showed increased N1 and reduced F

181 Bipolar disorder has a unique U-shaped association with

182 Lithium responsivity in patients with bipolar disorder has been genetically associated with Ph

183 Although the importance of activation in bipolar disorders has been acknowledged for more than a

184 regarding lithium's antisuicidal effect for bipolar disorder have been limited due to nonrepresentat

185 Patients with bipolar disorder have recurrent major depression, residu

186 ctorial trial (CEQUEL), patients with DSM-IV bipolar disorder I or II, who were aged 16 years or olde

187 or either major depressive disorder (MDD) or bipolar disorder I/II and who were currently experiencin

188 transcripts are altered in schizophrenia or bipolar disorder in comparison with non-psychiatric cont

189 n of activation as a criterion A symptom for bipolar disorder in DSM-5.

190 fy building blocks of complex illnesses like bipolar disorder in hopes of uncovering the neurobiology

191 Further, translating the biology of bipolar disorder in humans into animal models has led to

192 Parental mood disorders (and bipolar disorder in particular) conferred more modest ri

193 Bipolar disorder is a diagnostically heterogeneous disor

194 Bipolar disorder is a heritable disorder characterized b

195 nd similarities between major depression and bipolar disorder is a necessary step to better understan

196 Bipolar disorder is a recurrent chronic disorder charact

197 Bipolar disorder is associated with high risk for suicid

198 Rapid cycling (RC) bipolar disorder is considered as a severe course of bip

199 Accurate diagnosis of bipolar disorder is difficult in clinical practice becau

200 stabilizers, careful assessment to rule out bipolar disorder is indicated before initiating monother

201 der, but it is unclear whether rapid cycling bipolar disorder is linked to highly altered membrane ph

202 rmacological and psychological strategies in bipolar disorder is of utmost importance.

203 Bipolar disorder is often misdiagnosed as major depressi

204 Bipolar disorder is one of the main causes of disability

205 ssing evidence that risky decision-making in bipolar disorder is related to reward-based differences

206 er, in a substantial number of patients with bipolar disorder, long-term lithium therapy comes at the

207 ts that predispose to schizophrenia, autism, bipolar disorder, major depression and attention deficit

208 er, autism spectrum disorder, schizophrenia, bipolar disorder, major depression, generalized anxiety

209 o, childhood cognitive ability, neuroticism, bipolar disorder, major depressive disorder and schizoph

210 ultiple neuropsychiatric disorders including bipolar disorder, major depressive disorder, and schizop

211 o, attention deficit hyperactivity disorder, bipolar disorder, major depressive disorder, neuroticism

212 was found for autism but not schizophrenia, bipolar disorder, major depressive disorder, or attentio

213 high complexity and the high heritability of bipolar disorder make it a compelling candidate for neur

214 r mania, however, depressed individuals with bipolar disorder may differ from those with major depres

215 thogenesis of psychiatric disorders, such as bipolar disorder, may be ascribed to a complex gene-envi

216 ve disorder, and 129 patients with psychotic bipolar disorder (mean [SD] age, 35.1 [12.0] years; 281

217 roup psychoeducation, early in the course of bipolar disorder might have important benefits on the co

218 zophrenia spectrum disorders (n = 34903) and bipolar disorder (n = 29692), as well as unaffected cont

219 MN was examined in three related conditions: bipolar disorder (n = 9), unaffected first-degree relati

220 s old, and individuals diagnosed with either bipolar disorder (N=34) or major depressive disorder (N=

221 s old, and individuals diagnosed with either bipolar disorder (N=34) or major depressive disorder (N=

222 tic groups (major depressive disorder, N=32; bipolar disorder, N=50; schizophrenia, N=51; psychosis r

223 ry variants across autism, schizophrenia and bipolar disorder NGS cohorts demonstrating their impact

224 ychosis, and half the cases of conversion to bipolar disorder occurred within 4.4 years.

225 ng and significant protective effect against bipolar disorder (odds ratio = .31) and schizophrenia (o

226 or Health and Care Excellence guidelines for bipolar disorder offer a number of recommendations for t

227 s; 1.44, 1.13-1.83, p=0.003), earlier age of bipolar disorder onset (14 studies, 5733 participants; 1

228 hs, or were cognitively impaired, or who had bipolar disorder or psychosis or psychotic symptoms.

229 d until first occurrence of schizophrenia or bipolar disorder or until death, emigration, or August 2

230 each fits together to produce syndromes like bipolar disorder or why so many mental illnesses co-occu

231 of schizophrenia, schizoaffective disorder, bipolar disorder, or other psychotic illness according t

232 iagnosis of major depressive disorder (MDD), bipolar disorder, or schizoaffective disorder.

233 turalistic study, 907 adult outpatients with bipolar disorder participating in the Stanley Foundation

234 and phenomenology of mixed depression among bipolar disorder patients and qualitatively compared a r

235 probands with schizophrenia (SZ), psychotic bipolar disorder (PBD), and schizoaffective disorder; th

236 In women with bipolar disorder, postpartum relapse rates were signific

237 thium carbonate, a drug for the treatment of bipolar disorder, provides mood stability to mitigate re

238 or depression, presence of a suicidal plan, bipolar disorder, psychosis, posttraumatic stress disord

239 32; 95% confidence interval: 0.30-0.33) than bipolar disorder (r=0.23; 0.21-0.25), and large proporti

240 The comparison between unipolar and bipolar disorders revealed a greater decrease in FA in t

241 preparations remain first-line treatment for bipolar disorder, risk for development of renal insuffic

242 95% CI, 0.30-0.88) and for individuals with bipolar disorder (RR, 0.42; 95% CI, 0.17-0.69) and schiz

243 While bipolar disorder's cyclicity is difficult to represent i

244 Inpatient diagnoses of bipolar disorder, schizoaffective disorder, schizophreni

245 dies have suggested SORCS2 to confer risk of bipolar disorder, schizophrenia and attention deficit-hy

246 p of MDD and subtypes with psychiatric (MDD, bipolar disorder, schizophrenia) and metabolic (body mas

247 k of severe mental illness in offspring (eg, bipolar disorder, schizophrenia).

248 rcuitry (Body-Mass Index, Obesity) or dlPFC (Bipolar disorder, Schizophrenia).

249 isorder, addiction, social anxiety disorder, bipolar disorder, schizophrenia, and attention-deficit/h

250 matic stress disorder, depressive disorders, bipolar disorder, schizophrenia, and substance use disor

251 Bipolar disorder, schizophrenia, autism and intellectual

252 inth Edition, Clinical Modification code for bipolar disorder, schizophrenia, or other psychotic diso

253 s of a mental disorder (depressive disorder, bipolar disorder, schizophrenia, substance use disorder,

254 rst-listed diagnoses of depressive disorder, bipolar disorder, schizophrenia, substance use disorder,

255 s with a schizophrenia spectrum disorder and bipolar disorder showed similar abnormalities.

256 Participants with DMDD and bipolar disorder showed similar levels of irritability a

257 e highly recurrent and progressive course of bipolar disorder sometimes even in the face of conventio

258 Systematic Treatment Enhancement Program for Bipolar Disorder study, the authors analyzed point preva

259 revealed that all phenotypes (schizophrenia, bipolar disorder, substance misuse, and violent crime) w

260 f self-inflicted injuries, major depression, bipolar disorder, substance use disorder, and other ment

261 mportant given that up to 20% of people with bipolar disorder suffer from comorbid ADHD.

262 enetically more similar to schizophrenia and bipolar disorder than adult-onset MDD.

263 tly lower in patients with schizophrenia and bipolar disorder than in control participants, even when

264 ers that may be relevant to the treatment of bipolar disorder that can be tested in future clinical t

265 wever, for adults with psychotic disorder or bipolar disorder, the additional costs of involuntary co

266 idence for calcium signalling dysfunction in bipolar disorder, the therapeutic candidacy of this clas

267 In 17 patients with rapid cycling bipolar disorder, time-series analyses detected synchron

268 of the clinical phenomenon of activation in bipolar disorder, to determine whether activation is sta

269 hiatric conditions, including schizophrenia, bipolar disorder, Tourette's syndrome, dementia, alcohol

270 apeutic relevance of inositol depletion as a bipolar disorder treatment.

271 sphocholine plus phosphocholine (GPC+PC)) in bipolar disorder using in vivo proton magnetic resonance

272 Bipolar disorder was associated with high (HR, 1.21; 95%

273 rs found that trait-related vulnerability to bipolar disorder was associated with reduced resting-sta

274 Bipolar disorder was associated with reduced white matte

275 158 patients with schizophrenia spectrum or bipolar disorder, we assigned 58 771 (78%) to the deriva

276 k in patients with schizophrenia spectrum or bipolar disorder, we describe the derivation of a score

277 enriched for antipsychotics, while those for bipolar disorder were enriched for both antipsychotics a

278 with a history of psychosis or rapid-cycling bipolar disorder were excluded.

279 national registers, 51,535 individuals with bipolar disorder were followed from 2005 to 2013 for tre

280 Patients with bipolar disorder were significantly less likely to exper

281 th subthreshold hypomania (SBP; subthreshold bipolar disorder) were indistinguishable from those with

282 t of patients with schizophrenia spectrum or bipolar disorder, which can be used as an adjunct to dec

283 METHOD: The study had 26 participants with bipolar disorder who had a prior suicide attempt (the at

284 es, the authors identified 2,307 adults with bipolar disorder who initiated therapy with methylphenid

285 es, the authors identified 2,307 adults with bipolar disorder who initiated therapy with methylphenid

286 treatment-emergent mania among patients with bipolar disorder who were concomitantly receiving a mood

287 14, with either major depressive disorder or bipolar disorder who were enrolled in one or more of 18

288 ts included all patients diagnosed as having bipolar disorder who were prescribed lithium, valproate,

289 behaviors and domains involved in mania and bipolar disorder will ultimately inform movement toward

290 s study of adolescents and young adults with bipolar disorder with and without a history of suicide a

291 Clinicians treating older patients with bipolar disorder with mood stabilizers need evidence fro

292 schizophrenia, schizoaffective disorder, and bipolar disorder with psychosis (N=711), their first-deg

293 r dopamine synthesis capacity is elevated in bipolar disorder with psychosis and how this compares wi

294 ectly examined in individuals diagnosed with bipolar disorder with psychosis.

295 thium should be considered for patients with bipolar disorder with suspected suicidal intentions, alt

296 re mental illness (schizophrenia spectrum or bipolar disorder) with 574 018 patient episodes between

297 he attempter group) and 42 participants with bipolar disorder without a suicide attempt (the nonattem

298 .88-2.70, p<0.0001) compared with those with bipolar disorder without childhood maltreatment.

299 as been much less investigation of mGluR5 in bipolar disorder, yet initial studies indicate that mGlu

300 Bipolar disorders yielded the lowest dissociation scores